Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

NCT00285389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Adriblastin
DRUG: dexamethasone
DRUG: Chlorambucil
DRUG: rituximab
DRUG: cyclophosphamide
DRUG: alkeran
PROCEDURE: Total body irradiation (8Gy/4fr)
DRUG: vincristine

Sponsor

French Innovative Leukemia Organisation

Collaborators

[object Object]